Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Hauser

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|July 23, 2022
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumoniaRoxane Rohani, Marc H Scheetz, Helen K Donnelly, et al.
The Journal of Infectious Diseases|October 31, 2025
Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic FibrosisSumitra D Mitra, Maulin Soneji, Christopher M R Axline, et al.
Microbiology Resource Announcements|January 25, 2023
A Structural Systems Biology Approach to High-Risk CG23 Klebsiella pneumoniaeNicole L Inniss, Travis J Kochan, George Minasov, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2023
Individual meropenem epithelial lining fluid and plasma PK/PD target attainmentRoxane Rohani, Paul R Yarnold, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumoniaRyan Williamson, Marta Zurawska, Adrian Valadez, et al.
Microbiology Spectrum|December 12, 2024
Refined methodology for quantifying <i>Pseudomonas aeruginosa</i> virulence using <i>Galleria mellonella</i>Christopher M R Axline, Travis J Kochan, Sophie Nozick, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2025
Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMOAdrian Valadez, Marta Zurawska, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumoniaMarta Zurawska, Adrian Valadez, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2026
Identification of <i>Streptococcus pyogenes</i> isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitisDaniel B Amusin, Lacy M Simons, Dulce S Garcia, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of <i>Galleria mellonella</i> , Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure <i>Pseudomonas aeruginosa</i> VirulenceAliki Valdes, Christopher Axline, Travis J Kochan, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|July 23, 2022
Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumoniaRoxane Rohani, Marc H Scheetz, Helen K Donnelly, et al.
The Journal of Infectious Diseases|October 31, 2025
Culture and Adaptation of Pseudomonas aeruginosa During Early Infection in Children With Cystic FibrosisSumitra D Mitra, Maulin Soneji, Christopher M R Axline, et al.
Microbiology Resource Announcements|January 25, 2023
A Structural Systems Biology Approach to High-Risk CG23 Klebsiella pneumoniaeNicole L Inniss, Travis J Kochan, George Minasov, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2023
Individual meropenem epithelial lining fluid and plasma PK/PD target attainmentRoxane Rohani, Paul R Yarnold, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumoniaRyan Williamson, Marta Zurawska, Adrian Valadez, et al.
Microbiology Spectrum|December 12, 2024
Refined methodology for quantifying <i>Pseudomonas aeruginosa</i> virulence using <i>Galleria mellonella</i>Christopher M R Axline, Travis J Kochan, Sophie Nozick, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2025
Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMOAdrian Valadez, Marta Zurawska, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumoniaMarta Zurawska, Adrian Valadez, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2026
Identification of <i>Streptococcus pyogenes</i> isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitisDaniel B Amusin, Lacy M Simons, Dulce S Garcia, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of <i>Galleria mellonella</i> , Epithelial Cell Cytotoxicity, and Mouse Model of Bacteremia to Measure <i>Pseudomonas aeruginosa</i> VirulenceAliki Valdes, Christopher Axline, Travis J Kochan, et al.
Pageof 13